We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SEB SA | AQEU:SKP | Aquis Europe | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 87.60 | 87.60 | 87.60 | 0.00 | 00:00:00 |
RNS Number:4177Q Skyepharma PLC 01 October 2003 1 October 2003 Immediate Release SkyePharma PLC ("the Company") As a result of transactions on 30 September 2003 by the SkyePharma PLC Share Purchase Plan (an Inland Revenue approved all employee share purchase plan), Michael Ashton and Donald Nicholson, directors of the Company, as trustees of the Plan, became the beneficial owners of an additional 5,612 Ordinary Shares of the Company, bringing the total held by the Plan to 83,246 Ordinary Shares of the Company. As a result the executive directors of the Company have the following additional interests as a result of their personal participation in the Plan:- Partnership Matching Total number of Shares purchased Shares awarded Partnership and on 30 September 2003 on 30 September Matching Shares held at #0.58 per 2003 at #0.58 on 30 September 2003. share per share Ian Gowrie-Smith 215 215 3,564 Michael Ashton 216 216 8,994 Donald Nicholson 216 216 8,994 In accordance with the rules of the Plan these directors have been awarded the Matching Shares on the basis of one Matching Share for each Partnership Share. The beneficial ownership of the Matching Shares will pass to the directors in three years time subject to continued employment and the retention of the underlying Partnership Shares. - ends - This information is provided by RNS The company news service from the London Stock Exchange END RDSFSEFLFSDSELS
1 Year SEB Chart |
1 Month SEB Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions